| Literature DB >> 18492292 |
Wei-Tsung Kao1, Yung-Chieh Yen, For-Wey Lung.
Abstract
BACKGROUND: Explore the interaction between apolipoprotein E (Apo E), phospholipase A2 (PLA2) and beta2 adrenergic receptor (beta2-AR) gene polymorphisms and lipid profiles in an elderly Chinese population.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18492292 PMCID: PMC2430561 DOI: 10.1186/1476-511X-7-20
Source DB: PubMed Journal: Lipids Health Dis ISSN: 1476-511X Impact factor: 3.876
Comparison of Participating and Nonparticipating Subjects
| Age (yr) Mean (SDs) | 69.18 (2.727) | 69.18 (2.832) | 0.990 |
| Sex | 0.148 | ||
| Male (%) | 157 (58.8) | 122 (52.4) | |
| Female (%) | 110 (41.2) | 111 (47.6) | |
| Education | 0.013 | ||
| Illiterate (%) | 117 (43.8) | 128 (54.9) | |
| Primary school or above (%) | 150 (56.2) | 105 (45.1) | |
| Monthly income (USD) | 0.107 | ||
| <$860 (%) | 193 (72.3) | 190 (81.5) | |
| $860~2,000 (%) | 59 (22.1) | 33 (14.2) | |
| $2,001~2,860 (%) | 12 (4.5) | 8 (3.4) | |
| >$2,860 (%) | 3 (1.1) | 2 (0.9) |
*The P values for the percentages of sex, education, and monthly income refer to X2 tests of differences between participating and nonparticipating subjects. For age, the P value refers to the t-test of differences between participating and nonparticipating subjects.
β2-AR Genotype Frequencies and Plasma Lipids Among Genetically Unrelated Elderly Ethnic Chinese Individuals
| Lipid level* | ||||
| TC | 282.0 | 200.0 (23.1) | 215.15 (40.2) | 0.129 |
| HDL-C | 47.0 | 45.3 (12.4) | 51.13 (14.1) | 0.422 |
| LDL-C | 204.0 | 129.7 (18.8) | 137.42 (35.9) | 0.138 |
| VLDL-C | 31.0 | 25.0 (10.5) | 26.67 (15.4) | 0.906 |
| TG | 151.0 | 127.0 (53.9) | 133.52 (77.1) | 0.940 |
| Lipid level* | ||||
| TC | 216.47 (40.862) | 216.10 (41.5) | 209.35 (39.2) | 0.770 |
| HDL-C | 51.92 (14.588) | 50.97 (14.8) | 51.22 (12.3) | 0.283 |
| LDL-C | 139.54 (36.410) | 138.03 (34.9) | 131.70 (36.5) | 0.679 |
| VLDL-C | 25.01 (13.626) | 27.28 (14.9) | 26.43 (18.9) | 0.512 |
| TG | 125.28 (68.208) | 136.82 (74.7) | 132.17 (94.4) | 0.527 |
| Lipid level* | ||||
| TC | 216.42 (40.287) | 190.63 (35.7) | 282.0 | 0.007 |
| HDL-C | 51.20 (14.276) | 47.21 (11.1) | 47.0 | 0.475 |
| LDL-C | 138.36 (35.378) | 121.21 (33.0) | 204.0 | 0.022 |
| VLDL-C | 26.95 (15.590) | 22.21 (8.8) | 31.0 | 0.410 |
| TG | 134.90 (78.011) | 112.11 (45.3) | 151.0 | 0.443 |
*Lipid level: mean (SDs) (mg/dL)
† The P values for all variables refer to F tests of differences between theβ2-AR genotype categories.
The Parsimonious Model for TC, HDL-C and LDL-C
| TC | HDL-C | LDL-C | ||||
| Variables | Coef (S.E.) | P | Coef (S.E.) | P | Coef (S.E.) | P |
| ε2allele effect | 9.9(13.9) | 0.474 | 11.0(5.1) | 0.032 | 2.2(12.2) | 0.860 |
| A2 allele effect | -9.6(5.0) | 0.057 | 1.3(1.8) | 0.486 | -9.3(4.4) | 0.037 |
| Glu effect | -16.1(9.5) | 0.092 | -2.9(3.5) | 0.401 | -8.2(8.4) | 0.333 |
| Sex | 12.1(5.1) | 0.018 | 4.2(1.9) | 0.027 | 6.3(4.5) | 0.164 |
| Age | -1.8(0.9) | 0.053 | 0.3(0.3) | 0.442 | -1.7(0.8) | 0.039 |
ε2allele effect: Apoε2 vs. Non-Apoε2, A2 allele effect: PLA2 A2 vs. Non-PLA2 A2.
Glu effect: Genotype Glu/Glu, Gln/Glu vs. Genotype Gln/Gln in Gln27Glu Genotypes of β2-AR gene. Sex: female vs. male
TC: Total cholesterol; HDL-C: high-density lipoprotein cholesterol; LDL-C: Low-density lipoprotein cholesterol
Coef: Estimate coefficient; S.E.: Standard error; P: P value
Plasma Lipids by Different β2-AR Gene Haplotypes Among Genetically Unrelated Elderly Chinese Individuals
| TC | 214.69 (41.060) | 214.66 (40.298) | 0.994 |
| HDL-C | 51.11 (14.285) | 50.74 (14.044) | 0.841 |
| LDL-C | 138.64 (36.229) | 136.49 (35.255) | 0.638 |
| VLDL-C | 24.95 (13.279) | 27.54 (16.246) | 0.185 |
| TG | 125.03 (66.570) | 137.88 (81.280) | 0.190 |
| TC | 215.38 (39.954) | 184.00 (55.328) | 0.060 |
| HDL-C | 50.98 (14.182) | 46.33 (10.013) | 0.426 |
| LDL-C | 137.68 (35.176) | 119.50 (50.087) | 0.216 |
| VLDL-C | 26.81 (15.377) | 18.17 (5.456) | 0.171 |
| TG | 134.27 (76.960) | 90.17 (26.947) | 0.163 |
| TC | 209.82 (39.488) | 215.66 (40.715 | 0.379 |
| HDL-C | 51.31 (12.387) | 50.78 (14.455) | 0.819 |
| LDL-C | 132.07 (36.841) | 138.33 (35.276) | 0.283 |
| VLDL-C | 26.44 (19.113) | 26.65 (14.416) | 0.936 |
| TG | 132.22 (95.497) | 133.49(72.206) | 0.919 |
| TC | 215.05 (40.399) | 165.00 (18.385) | 0.082 |
| HDL-C | 50.81 (14.138) | 59.50 (2.121) | 0.386 |
| LDL-C | 137.65 (35.377) | 87.00 (26.870) | 0.045 |
| VLDL-C | 26.67 (15.311) | 18.50 (6.364) | 0.452 |
| TG | 133.57 (76.639) | 94.50 (36.648) | 0.473 |
| TC | 214.98 (40.812) | 207.45 (40.812) | 0.547 |
| HDL-C | 51.11 (14.171) | 45.45 (33.040) | 0.194 |
| LDL-C | 137.30 (35.870) | 136.45 (28.623) | 0.939 |
| VLDL-C | 26.66 (15.470) | 25.55 (10.152) | 0.814 |
| TG | 133.45 (77.416) | 129.18 (51.610) | 0.856 |
*Lipid level: mean (SDs) (mg/dL); † The P values for all variables refer to T tests of differences between the two groups.
TGC: Cys19Gly16Gln27; TGG: Cys19Gly16Glu2 ; TAC: Cys19Arg16Gln; TAG: Cys19Arg16Glu27; CGG: Arg19Gly16Glu27